Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: Results of a multicenter phase 2 trial

Blood

Volumn 120, Issue 18, 2012, Pages 3858-3860

  Ferreri, Andrés J M ^a   Govi, Silvia ^a   Raderer, Markus ^b   Mulè, Antonino ^c   Andriani, Alessandro ^d   Caracciolo, Daniele ^e   Devizzi, Liliana ^f   Ilariucci, Fiorella ^g   Luminari, Stefano ^h   Viale, Edi ^a   Müllauer, Leonhard ^b   Dell'Oro, Stefania ^a   Arcidiacono, Paolo Giorgio ^a   Ponzoni, Maurilio ^a   Patti, Caterina ^c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^d Ospedale Regina Margherita   (Italy)

^e Universitaria San Giovanni Battista   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g S MARIA NUOVA HOSPITAL   (Italy)

^h UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; TINIDAZOLE;

DISEASE CONTROL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LARGE CELL LYMPHOMA; LETTER; LYMPHADENOPATHY; NONHUMAN; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84868609127     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-438424     Document Type: Letter

References (7)

1. Kuo SH, Yeh KH, Wu MS, et al. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas. Blood. 2012;119(21):4838-4844.
2. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275-282. (Pubitemid 38029949)
3. Tari A, Asaoku H, Kashiwado K, et al. Predictive value of endoscopy and endoscopic ultrasonography for regression of gastric diffuse large B-cell lymphomas after Helicobacter pylori eradication. Dig Endosc. 2009;21(4):219-227.
4. Ferreri AJ, Freschi M, Dell'Oro S, Viale E, Villa E, Ponzoni M. Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-cell gastric lymphomas. Am J Surg Pathol. 2001;25(1):95-102. (Pubitemid 32001838)
5. Morgner A, Miehlke S, Fischbach W, et al. Complete remission of primary highgrade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol. 2001;19(7):2041-2048. (Pubitemid 32702549)
6. Swerdlow SH, Campo E, Harris NL, Pileri S, et al. WHO classification of tumors of Haematopoietic and Lymphoid Tissues. 4th Ed. Lyon, France: IARC Press; ed. 2008.
7. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17(4):1244.